140 related articles for article (PubMed ID: 1186087)
21. M-components in patients with chronic liver disease.
Ellman LL; Pachas WN; Pinals RS; Bloch KJ
Gastroenterology; 1969 Aug; 57(2):138-42. PubMed ID: 5799671
[No Abstract] [Full Text] [Related]
22. [Phagocytic activity of the leukocytes in chronic glomerulonephritis].
Miroshnichenko NG; Poliantseva LR; Kozlovskaia LV
Ter Arkh; 1980; 52(4):31-5. PubMed ID: 7404335
[No Abstract] [Full Text] [Related]
23. [State of the coagulation and anticoagulation systems of the blood in chronic hepatitis and liver cirrhosis].
Mokhov VM
Ter Arkh; 1971 Jul; 43(6):73-6. PubMed ID: 5125990
[No Abstract] [Full Text] [Related]
24. [Significance of various diagnostic parameters in chronic liver diseases].
Heinicke HJ
Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734
[No Abstract] [Full Text] [Related]
25. [Importance of the determination of blood kallikreinogen level in chronic liver diseases].
Bondar' ZA; Paskhina TS; Krinskaia AV; Melkumova IS
Sov Med; 1978 Feb; (2):72-6. PubMed ID: 635707
[No Abstract] [Full Text] [Related]
26. [Changes in the levels of serum zinc in chronic hepatopathy].
Orlando R; Tosone G; De Fino M; Cangiano F
Minerva Med; 1987 Dec; 78(23):1759-63. PubMed ID: 3696451
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
[No Abstract] [Full Text] [Related]
28. [Serum free amino acid concentrations in liver diseases].
Triapyshko AD
Ter Arkh; 1971 Apr; 43(4):66-70. PubMed ID: 5123443
[No Abstract] [Full Text] [Related]
29. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
Lampe K; Hüdepohl M; Schopen RD
Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
[No Abstract] [Full Text] [Related]
30. [Dynamics of concentration of insulin and growth hormone in blood serum in chronic liver diseases].
Shlimovich PB; Sokolov IaA; Moskvichev AM
Klin Med (Mosk); 1976 Jun; 54(6):90-5. PubMed ID: 972523
[No Abstract] [Full Text] [Related]
31. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
[No Abstract] [Full Text] [Related]
32. [The treatment of some resistant dermatoses with pyrogenal].
Fel'ker AIa
Vestn Dermatol Venerol; 1973 Jan; 47(1):81-3. PubMed ID: 4709902
[No Abstract] [Full Text] [Related]
33. [Diagnostic value of serum bile acids in chronic diseases of the liver].
Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
[No Abstract] [Full Text] [Related]
34. [Dynamics of malate and lactate dehydrogenase isoenzyme activity in the treatment of liver cirrhosis in children with pyrogenal].
Savel'eva LA; Zaprudnov AM; Iurkov IuA
Vopr Okhr Materin Det; 1969 Oct; 14(10):67-70. PubMed ID: 5381151
[No Abstract] [Full Text] [Related]
35. [Phagocytosis and intracellular metabolism of the blood leukocytes in viral hepatitis].
Veprinskaia SI; Traĭbich ShA
Vrach Delo; 1975 Feb; (2):142-5. PubMed ID: 1136393
[No Abstract] [Full Text] [Related]
36. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
Collazos J; Mendarte U; De Miguel J
Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
[TBL] [Abstract][Full Text] [Related]
37. [Effect of biphenyl dicarboxylate on abnormal laboratory findings in patients with chronic hepatitis and liver cirrhosis].
Yu HQ
Zhong Xi Yi Jie He Za Zhi; 1983 May; 3(3):163-4. PubMed ID: 6193897
[No Abstract] [Full Text] [Related]
38. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
Kurdybaĭlo FV; Larina IG; Kulikova AN
Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
[No Abstract] [Full Text] [Related]
39. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
40. [Fasting and postprandial serum bile acids in chronic liver diseases].
Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
